Literature DB >> 8888220

Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.

M S Peterson1, R L Baron, T Murakami.   

Abstract

PURPOSE: To determine whether liver tumor detection is increased by acquiring multiple dynamic arterial phase and portal venous phase magnetic resonance (MR) images.
MATERIALS AND METHODS: Dynamic MR imaging was performed in 205 patients at 1.5 T with use of a fast spoiled gradient-echo technique (repetition time, 9-12 msec; echo time, 2.1-3.0 msec; flip angle, 30 degrees). During intravenous bolus injection of gadopentetate dimeglumine or gadoteridol (0.1 mmol/kg), nine images were acquired at each of 10-12 locations over approximately 120 seconds. The number of tumors detected on arterial phase and portal venous phase images and unenhanced T1- and T2-weighted spin-echo (SE) images was evaluated separately. Data obtained in 75 patients with proved malignancies were analyzed.
RESULTS: At imaging, 220 malignant tumor nodules were depicted. At prospective review of all images, 110 hepatocellular carcinomas (HCCs) were detected: 82 (75%) on unenhanced T1-weighted SE images, 83 (75%) on unenhanced T2-weighted SE images, 92 (84%) on arterial phase images, and 76 (69%) on portal venous phase images. At prospective review, eight HCCs were detected on only arterial phase images, one on only portal venous phase images, nine on both arterial and portal venous phase images, and 11 on only unenhanced SE images. The 18 additional HCCS detected prospectively on only dynamic images increased HCC detection by 21% over prospective detection on only SE images. Detection of non-HCC tumors (including metastases) did not increase with dynamic images.
CONCLUSION: Acquisition of multiple dynamic arterial phase and portal venous phase images increased detection of HCC but not metastases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888220     DOI: 10.1148/radiology.201.2.8888220

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning.

Authors:  Hong Zhao; Jin-Lin Yao; Ying Wang; Kang-Rong Zhou
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

2.  Utility of 3D magnetic resonance imaging in preoperative evaluation of hepatobiliary diseases.

Authors:  R Tongdee; V R Narra; E P Oliveira; W Chapman; K M Elsayes; J J Brown
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Authors:  C S Peña; S Saini; R L Baron; B A Hamm; G Morana; R Caudana; A Giovagnoni; A Villa; A Carriero; D Mathieu; M W Bourne; M A Kirchin; G Pirovano; A Spinazzi
Journal:  Korean J Radiol       Date:  2001 Oct-Dec       Impact factor: 3.500

4.  Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma.

Authors:  Seishi Kumano; Masahiko Uemura; Toyoaki Haraikawa; Masaaki Hirata; Keiichi Kikuchi; Tonsok Kim; Masahiro Okada; Teruhito Mochizuki; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2009-07-22       Impact factor: 2.374

5.  Prospective comparison of high- and low-spatial-resolution dynamic MR imaging with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinoma.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Kensuke Uotani; Koji Sugimoto; Masahiko Fujii; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-30       Impact factor: 5.315

6.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

7.  Patient selection for hepatic resection for metastatic colorectal cancer.

Authors:  Matthew J Weiss; Michael I D'Angelica
Journal:  J Gastrointest Oncol       Date:  2012-03

8.  Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Authors:  Shotaro Enomoto; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2011-01-09       Impact factor: 6.047

9.  Graphics Processing Unit-Accelerated Nonrigid Registration of MR Images to CT Images During CT-Guided Percutaneous Liver Tumor Ablations.

Authors:  Junichi Tokuda; William Plishker; Meysam Torabi; Olutayo I Olubiyi; George Zaki; Servet Tatli; Stuart G Silverman; Raj Shekher; Nobuhiko Hata
Journal:  Acad Radiol       Date:  2015-03-14       Impact factor: 3.173

10.  Higher lesion conspicuity for SENSE dynamic MRI in detecting hypervascular hepatocellular carcinoma: analysis through the measurements of liver SNR and lesion-liver CNR comparison with conventional dynamic MRI.

Authors:  Osamu Tanaka; Hirotoshi Ito; Kei Yamada; Takao Kubota; Osamu Kizu; Takeharu Kato; Takuji Yamagami; Tsunehiko Nishimura
Journal:  Eur Radiol       Date:  2005-07-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.